Results 1 to 10 of about 165,249 (191)

SIRT1 negatively regulates the mammalian target of rapamycin. [PDF]

open access: yesPLoS ONE, 2010
The IGF/mTOR pathway, which is modulated by nutrients, growth factors, energy status and cellular stress regulates aging in various organisms. SIRT1 is a NAD+ dependent deacetylase that is known to regulate caloric restriction mediated longevity in model
Hiyaa Singhee Ghosh   +2 more
doaj   +4 more sources

Mammalian Target of Rapamycin in Inflammatory Skin Conditions

open access: yesEuropean Journal of Inflammation, 2014
The conserved serine/threonine kinase mammalian target of rapamycin (mTOR) is a major regulator of survival growth, proliferation and motility, in response to mitogens, energy and nutrient levels.
A. Balato   +9 more
doaj   +2 more sources

Recent Advances in the Development of PI3K/mTOR-Based Anticancer Agents: A Mini Review [PDF]

open access: yesFolia Medica, 2021
Cancer refers to the group of diseases characterized by uncontrolled growth of abnormal cells. It spreads throughout the body which makes this disease one of the huge global threats to mankind.
Ishan Panchal   +4 more
doaj   +3 more sources

The Effects of Evening Primrose/Hemp Seed Oil Compared to Rapamycin on the Gene Expression of Immunological Parameters in Experimental Autoimmune Encephalomyelitis Splenocytes

open access: yesIranian Journal of Allergy, Asthma and Immunology, 2020
Mouse model of multiple sclerosis (MS) is used for the inflammatory demyelinating disease. Rapamycin (RAPA) may contribute to the reduction of inflammatory responses to experimental autoimmune encephalomyelitis (EAE).
Soheila Rezapour-Firouzi   +4 more
doaj   +1 more source

The Complexes of Mammalian Target of Rapamycin [PDF]

open access: yesCurrent Protein & Peptide Science, 2010
The mammalian target of rapamycin (mTOR) has attracted substantial attention because of its involvement in a variety of diseases, such as cancer, cardiac hypertrophy, diabetes and obesity. Current knowledge indicates that mTOR functions as two distinct multiprotein complexes, mTORC1 and mTORC2.
Hongyu, Zhou, Shile, Huang
openaire   +2 more sources

Eupafolin ameliorates lipopolysaccharide-induced cardiomyocyte autophagy via PI3K/AKT/mTOR signaling pathway [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2019
Objective(s): Eupafolin, a major active component of Eupatorium perfoliatum L., has anti-inflammatory and anti-oxidant properties. Lipopolysaccharide (LPS) is responsible for myocardial depression.
Yan Gao, Yi Zhang, Yangyang Fan
doaj   +1 more source

The Potential and Limitations of Precision Oncology: Lessons Learned from Whole-Exome Sequencing in an Exceptional Response to Everolimus in Advanced Renal Cell Carcinoma

open access: yesCase Reports in Oncology, 2021
Through elucidating the genetic mechanisms of drug sensitivity, precision medicine aims to improve patient selection and response to therapy. Exceptional responders are patients that exhibit exquisite and durable responses to targeted therapy, providing ...
Amanda Pilling   +7 more
doaj   +1 more source

Insulin signaling in insulin resistance states and cancer: A modeling analysis [PDF]

open access: yes, 2016
Insulin resistance is the common denominator of several diseases including type 2 diabetes and cancer, and investigating the mechanisms responsible for insulin signaling impairment is of primary importance.
Bertuzzi, Alessandro   +5 more
core   +14 more sources

Mammalian target of rapamycin activity is required for expansion of CD34+ hematopoietic progenitor cells

open access: yesHaematologica, 2009
Background The mammalian target of rapamycin is a conserved protein kinase known to regulate protein synthesis, cell size and proliferation. Aberrant regulation of mammalian target of rapamycin activity has been observed in hematopoietic malignancies ...
Christian R. Geest   +4 more
doaj   +1 more source

Rapamycin induces transactivation of the EGFR and increases cell survival. [PDF]

open access: yes, 2009
The mammalian target of rapamycin (mTOR) signaling network regulates cell growth, proliferation and cell survival. Deregulated activation of this pathway is a common event in diverse human diseases such as cancers, cardiac hypertrophy, vascular ...
Chaturvedi, D   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy